Partnerships & Mergers
-
Kyowa Kirin signs exclusive Poteligeo distribution deal with Knight Therapeutics in Latin America
The deal gives Kyowa Kirin access to Knight’s pan-American commercial infrastructure while allowing Knight to add a targeted oncology therapy to its portfolio.
-
HPE deploys AI-powered networking at Saudi German Health UAE to support digital transformation
Saudi German Health UAE selected HPE’s Self Driving Network portfolio to upgrade its wired, wireless and security infrastructure across its hospitals, clinics, medical education facilities and new medical college.
-
ADNOC partners with Burjeel Holdings to expand integrated healthcare services in Al Dhafra region
The initiative builds on the partnership that began after ADNOC appointed Burjeel Holdings as the medical operator of Al Dhannah Hospital in 2023.
-
Vertex expands partnership with MNGHA to advance gene therapy care in Saudi Arabia
The announcement was made at the Riyadh Global Medical Biotechnology Summit (RGMBS), building on a collaboration established after Saudi Arabia’s first gene therapy infusion in 2024.
-
Sandoz expands biosimilar pipeline with mAbxience deal for haemophilia A treatment
The agreement covers licensing, development, manufacturing and commercialisation of the candidate, which is currently in the early stages of development.
-
WuXi XDC licenses ADC technology to Ona Therapeutics
The arrangement gives Ona Therapeutics access to WuXi XDC’s capabilities across ADC development and manufacturing as it advances the candidate towards clinical development.
-
Roche strikes US$1B bispecific antibody discovery deal with Dualitas Therapeutics
Roche will take responsibility for subsequent development activities, including preclinical research, and oversee the programmes as they progress towards potential commercialisation.
-
Emirates partners with Medical Tourism Association to expand healthcare travel services
The organisations will identify key markets and medical travel corridors, particularly across Africa, Asia and the Middle East, and develop travel solutions that address the needs of patients, referring physicians, insurers and employers.
-
Eli Lilly bets on Canadian biotech QurCan in genetic medicine delivery deal
QurCan will focus on developing and optimising genetic therapeutics using its delivery technology, while Lilly will take responsibility for advancing selected candidates through subsequent development stages.
-
Gilead expands global Lenacapavir reach through strategic PAHO partnership
The partnership complements existing mechanisms for supplying generic versions of lenacapavir and aims to address gaps in HIV prevention across the region.